Changes in renal function induced by endralazine, a new antihypertensive drug.
D000450:Aldosterone / Q000097:blood; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D005919:Glomerular Filtration Rate; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007668:Kidney / Q000187:drug effects*; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D009318:Natriuresis / Q000187:drug effects; D011188:Potassium / Q000378:metabolism; D011724:Pyridazines / Q000009:adverse effects* / Q000627:therapeutic use; D012079:Renal Circulation / Q000187:drug effects; D012083:Renin / Q000097:blood; D014508:Urea / Q000378:metabolism
D000959:Antihypertensive Agents; D011724:Pyridazines; C014926:BQ 22-708; D000450:Aldosterone; D014508:Urea; D012083:Renin; D011188:Potassium